S. Devi, H. Hagiyama, T. Adachi, N. Miyasaka, T. Tsubata
{"title":"The tumor suppressor p53 is not required for antigen receptor‐mediated apoptosis of B lymphocytes","authors":"S. Devi, H. Hagiyama, T. Adachi, N. Miyasaka, T. Tsubata","doi":"10.1002/SITA.200400033","DOIUrl":null,"url":null,"abstract":"The tumor suppressor p53 has been shown to be essential in apoptosis induced by irradiation, deregulated c-Myc expression and anti-cancer drugs. The protein level of p53 was moderately increased when the B cell line WEHI-231 undergoes apoptosis by B cell receptor (BCR) crosslinking. However, overexpression of a dominant negative form of p53, p53DD, abolished DNA binding activity of p53 almost completely but failed to block BCR-mediated death of WEHI-231, suggesting that p53-mediated transactivation is not required for BCR-mediated apoptosis of WEHI-231. Moreover, B cells of p53-deficient mice underwent cell death upon BCR crosslinking as efficiently as those of normal littermates, indicating that p53 is not essential for BCR-mediated apoptosis of normal B cells. Although a previous report suggested that p53 is required for BCR-mediated apoptosis through its transactivation, our data strongly argue that p53 is not required for BCR-mediated apoptosis.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"17 7","pages":"54-61"},"PeriodicalIF":0.0000,"publicationDate":"2006-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200400033","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Signal transduction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/SITA.200400033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The tumor suppressor p53 has been shown to be essential in apoptosis induced by irradiation, deregulated c-Myc expression and anti-cancer drugs. The protein level of p53 was moderately increased when the B cell line WEHI-231 undergoes apoptosis by B cell receptor (BCR) crosslinking. However, overexpression of a dominant negative form of p53, p53DD, abolished DNA binding activity of p53 almost completely but failed to block BCR-mediated death of WEHI-231, suggesting that p53-mediated transactivation is not required for BCR-mediated apoptosis of WEHI-231. Moreover, B cells of p53-deficient mice underwent cell death upon BCR crosslinking as efficiently as those of normal littermates, indicating that p53 is not essential for BCR-mediated apoptosis of normal B cells. Although a previous report suggested that p53 is required for BCR-mediated apoptosis through its transactivation, our data strongly argue that p53 is not required for BCR-mediated apoptosis.